Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Galantamine in Tic Disorders

This study has been terminated.
(Unable to recruit subjects into the trial.)
Sponsor:
Collaborator:
Ortho-McNeil Neurologics, Inc.
Information provided by:
Parkinson's Disease and Movement Disorders Center
ClinicalTrials.gov Identifier:
NCT00226824
First received: September 23, 2005
Last updated: August 21, 2009
Last verified: August 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2007
  Estimated Primary Completion Date: No date given